ES8502088A1 - Un procedimiento para preparar un compuesto de nitrato piridilalquilico - Google Patents

Un procedimiento para preparar un compuesto de nitrato piridilalquilico

Info

Publication number
ES8502088A1
ES8502088A1 ES524375A ES524375A ES8502088A1 ES 8502088 A1 ES8502088 A1 ES 8502088A1 ES 524375 A ES524375 A ES 524375A ES 524375 A ES524375 A ES 524375A ES 8502088 A1 ES8502088 A1 ES 8502088A1
Authority
ES
Spain
Prior art keywords
preparing
procedure
piridylalkyl
nitrate compound
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES524375A
Other languages
English (en)
Spanish (es)
Other versions
ES524375A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of ES524375A0 publication Critical patent/ES524375A0/es
Publication of ES8502088A1 publication Critical patent/ES8502088A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ES524375A 1982-07-26 1983-07-22 Un procedimiento para preparar un compuesto de nitrato piridilalquilico Expired ES8502088A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8221592 1982-07-26

Publications (2)

Publication Number Publication Date
ES524375A0 ES524375A0 (es) 1984-12-16
ES8502088A1 true ES8502088A1 (es) 1984-12-16

Family

ID=10531922

Family Applications (1)

Application Number Title Priority Date Filing Date
ES524375A Expired ES8502088A1 (es) 1982-07-26 1983-07-22 Un procedimiento para preparar un compuesto de nitrato piridilalquilico

Country Status (17)

Country Link
US (2) US4540701A (en, 2012)
EP (1) EP0100081B1 (en, 2012)
JP (1) JPS5951263A (en, 2012)
KR (1) KR900005470B1 (en, 2012)
AT (1) ATE40948T1 (en, 2012)
AU (1) AU565791B2 (en, 2012)
CA (1) CA1216850A (en, 2012)
DE (1) DE3379255D1 (en, 2012)
DK (1) DK311683A (en, 2012)
ES (1) ES8502088A1 (en, 2012)
FI (1) FI832490A7 (en, 2012)
GR (1) GR78629B (en, 2012)
HU (1) HU190497B (en, 2012)
NO (1) NO832700L (en, 2012)
PH (1) PH18083A (en, 2012)
SU (1) SU1189337A3 (en, 2012)
ZA (1) ZA835048B (en, 2012)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6081166A (ja) * 1983-10-11 1985-05-09 Fujisawa Pharmaceut Co Ltd 2−ニトロオキシメチル−6−クロロピリジンのβ−シクロデキストリン包接化合物およびその製造法
JPS6215A (ja) * 1985-02-26 1987-01-06 Fujisawa Pharmaceut Co Ltd 2−ニトロオキシメチル−6−クロロピリジンまたはそのβ−シクロデキストリン包接化合物含有持続性製剤
ZA885069B (en) * 1987-07-24 1989-03-29 Fujisawa Pharmaceutical Co Sustained-release percutaneous preparations
JPH02167279A (ja) * 1988-09-30 1990-06-27 Taisho Pharmaceut Co Ltd アポビンカミン酸誘導体
US5047543A (en) * 1988-11-24 1991-09-10 Taisho Pharmaceutical Co., Ltd. 1,4-dihydropyridine derivatives
CN106318877A (zh) * 2016-08-29 2017-01-11 刘翔 一种从茯砖茶中分离、纯化冠突散囊菌及其液态培养方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3275642A (en) * 1962-04-26 1966-09-27 Bard Pharmaceutical Inc 3-pyridine carbinol nitrate and its preparation
US3689494A (en) * 1971-03-31 1972-09-05 William R J Simpson N-pyridinealkyl-alkanolamine nitrates

Also Published As

Publication number Publication date
EP0100081A2 (en) 1984-02-08
NO832700L (no) 1984-02-06
DE3379255D1 (en) 1989-04-06
ES524375A0 (es) 1984-12-16
DK311683D0 (da) 1983-07-05
EP0100081A3 (en) 1985-05-02
JPS6350343B2 (en, 2012) 1988-10-07
FI832490L (fi) 1984-01-27
FI832490A7 (fi) 1984-01-27
DK311683A (da) 1984-01-27
SU1189337A3 (ru) 1985-10-30
US4540701A (en) 1985-09-10
KR840005426A (ko) 1984-11-12
AU565791B2 (en) 1987-10-01
FI832490A0 (fi) 1983-07-07
CA1216850A (en) 1987-01-20
PH18083A (en) 1985-03-18
EP0100081B1 (en) 1989-03-01
KR900005470B1 (ko) 1990-07-30
ZA835048B (en) 1984-03-28
US4613608A (en) 1986-09-23
AU1663583A (en) 1984-02-02
GR78629B (en, 2012) 1984-09-27
ATE40948T1 (de) 1989-03-15
JPS5951263A (ja) 1984-03-24
HU190497B (en) 1986-09-29

Similar Documents

Publication Publication Date Title
ES8505972A1 (es) Un procedimiento para preparar derivados de pirimidina
IT1167602B (it) Regolatore di primo stadio per respiratore subacqueo
ES461644A1 (es) Un procedimiento para preparar nuevos derivados de bencimi- dazol.
IT1063011B (it) Procedimento per la produzione di idrogeno
NL190902C (nl) Chemisch verguldbad.
IT7824178A0 (it) Procedimento di sintesi dell'acido ascorbico.
IT1066263B (it) Procedimento per la produzione di nastri di espanso poliolefinico
DK300587A (da) Hydrofoberings- og oleofoberingsmiddel og dettes anvendelse
ES8502088A1 (es) Un procedimiento para preparar un compuesto de nitrato piridilalquilico
IT1064675B (it) Procedimento per la produzione di cuoio artificiale
ES8703464A1 (es) Procedimiento para preparar pirazol (3,4-b) piridinamidas.
IT1124757B (it) Procedimento per la produzione di cuoi pellami e pellicce
FR2308639A1 (fr) Solution stable d'un coenzyme
IT1143678B (it) Procedimento per la clorurazione diretta di alchil-benzeni
ES8503676A1 (es) Procedimiento de producir derivados de acido oxazolacetico
IT1038805B (it) Sintesi di bis 2 n.n dimetila mino etil etere
ES8401963A1 (es) Un procedimiento para la preparacion de un derivado de piridoindol.
IT1081298B (it) Miscela di mangime
ES457803A1 (es) Procedimiento para la preparacion de derivados de benzodio- xol.
ES8405013A1 (es) Procedimiento para preparar derivados de tieno-tiazol
IT1083902B (it) Miscela di mangime
ES8505199A1 (es) Un procedimiento para la preparacion de derivados de difenilalquilenicos.
IT1164044B (it) Procedimento per neutralizzare elettricita' statica con atmosfere gassose miste
ES8401449A1 (es) "procedimiento para la preparacion de un diisocianato".
IT1066714B (it) Procedimento per la produzione di n n bis trimetil sililurea